abu-abeeleh, J. et al. 2015. SIMVASTATIN TREATMENT AMELIORATES DIABETIC TYPE 2 CONDITIONS THROUGH LOWERING THE CONCENTRATION OF PLASMA ICAM LEVELS. European Scientific Journal, ESJ. 11, 24 (Aug. 2015).